drugset
Drugs / Measles, Mumps, Rubella vaccination
last change May 2012 re-read 3 minutes ago

Measles, Mumps, Rubella vaccination

Vaccine

Developed for
juvenile idiopathic arthritis
Investigated by
Amsterdam UMC, location VUmc · Erasmus Medical Center · Maastricht University Medical Center · N.M. Wulffraat · University Medical Center Groningen

Trials 1

today NCT00731965 · Ph 4
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00731965 May 2008 → May 2012 juvenile idiopathic arthritis N.M. Wulffraat Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Measles, Mumps, Rubella vaccination ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731965 ↗
Modality Vaccine “live attenuated Measles, Mumps, Rubella (MMR) vaccination” NCT00731965 ↗
Route Subcutaneous “Dosage form: subcutaneously” NCT00731965 ↗